I think you might be right on the CE coming. The recent news suggests that the company has got all their ducks lined up. I think the recent move is just a taste of the re -rate on the CE. People can read about the requirements for getting a CE and OSL should have little problem from what i have read.
I cant see why it wont be issued and that would allow OSL to market in Europe. That is a bit like passing the FDA for a drug imo.
This would send the company into a strong position and it makes me wonder if one of the other medical device companies wont come knocking at that point. Sirtex is worth approx $1b.
dyor
Ann: Positive Early Study Results Presented at EANM Congress, page-73
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |